Retroperitoneal sarcoma represents approximately 12-15% of all sarcomas and between 0.2 and 0.5% of all neoplasia. They very rarely metastasize, and the main cause of death is local recurrence. Radiotherapy and chemotherapy still do not represent valid therapeutic alternatives, therefore radical